From the marketing stand point, you must protect your brand image/value at all cost. TITXF didn't foresee all of the lawsuits against ISRG until just a few months ago. ISRG knew the law suits were coming but they were just too busy making all the money and their ego (being a bully to the customers because they can and because they are the monopoly...why not) cost ISRG A LOT of money.
ISRG has dropped drastically (it was at $520+ just a few months ago) due to the lawsuits and it makes perfect sense for TITXF to change "Amedeus" to sport. I don't care about the meaning/origin of the word but it simply means "we will fail for sure" in my dictionary.
I am glad TITXF changed it to Sport, hopefully TITXF is not going to be the next MAKO.
The R&D money for Amedeus is gone and it's business. TITXF saved the company millions and millions of dollars by getting ride of Amedeus. No one wants to be associated with "da vinci" at this moment...not any time soon.
Personally, I don't like the name "Sport" but it sounds straight forward and predictable.
You have to believe in the product and the passion TITXF has to offer and you also have to understand situation ISRG is currently in right now and the market share ISRG owns. ISRG has not yet tap into to the Asia and Europe market yet and they are doing just FINE. TITXF has to tap into that billion dollar market share and we will win like a champ.
The R&D money for Amedeus is gone and again, it's business but if TITXF wants to raise more money then an explanation in regards to the R&D money would helpful.
I am not a surgeon but I sure agree with Daktari3; 1 procedure IMHO is not going to cut it. Customers always want something better but at fraction of cost and this is how you gain market share.
TITXF shouldn't have much of problem to raise the money they need. Keep posting more demo and engage with the market research group.
If you build it, they will come.
My prediction for TITXF - if they were able to launch the product successfully in 2018. The stock share would be about $20+ per share by the 3rd earning qt and in 2023 I'll have enough money laying around so I can trade FB ($500 per share).
In 2023:
MAKO filed bankruptcy or got bought out by TITXF/ISRG.
A medical company in China introduce a better product than SPORT/Da Vanci. TITXF/ISRG both sue China Med and lost.
Google - $1850 per share
Amazon - $400 per share
ALDI - $29 per share
News 
Market Data 
Discover 
